Please be advised  of the recent approval by the FDA for intramuscular Plegridy (Peginterferon beta-1a) and an update to other sections [...]
- (201) 487-1050
- 3 University Plz Dr Ste 116, Hackensack, NJ 07601
- info@mscare.org
CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.